Lupus study: Is CXCL5 linked to disease activity?
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study looks at a protein called CXCL5 in the blood of people with lupus (SLE) to see if it relates to how active their disease is. It will help researchers understand more about lupus and possibly find new ways to track or treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with lupus (SLE) according to the SLICC criteria.
- You cannot have another autoimmune disease besides lupus.
- You cannot have cancer or an active infection.
- You cannot be pregnant or breastfeeding.
- You must be willing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether two blood markers (AGR and PNI) can help track how active lupus is. You may be eligible if you have lupus and are not pregnant or have other serious health conditions.
This study looks at blood test results in children and teenagers with lupus to see if they relate to how active the disease is or if it has caused long-term damage. It may help doctors better understand the disease.
This study looks at a specific gene (ICOS) in people with lupus to better understand the condition. It involves a blood test to check for genetic markers.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at two blood markers (IgG and IgM) in people with lupus to see if they can help measure disease activity and damage. It may help doctors better understand and manage lupus.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
Hear when a new SLE (Systemic Lupus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.